Oxantel

Class: Fumarate reductase inhibitor

Spectrum of activity:	Gram-negative
Details of activity:	Chronic periodontitis: proteolytic species Porphyromonas gingivalis and Tannerella forsythia
Institute where first reported:	Oral Health CRC, Melbourne Dental School, Bio21 Institute, The University of Melbourne, Melbourne, Victoria, Australia
Year first mentioned:	1975
Highest developmental phase:	Preclinical
Development status:	Experimental

Chemical structure(s):
Canonical SMILES:	CN1CCCN=C1/C=C/C2=CC=CC(=C2)O
Isomeric SMILES:	CN1CCCN=C1/C=C/C2=CC(=CC=C2)O
InChI:	InChI=1S/C13H16N2O/c1-15-9-3-8-14-13(15)7-6-11-4-2-5-12(16)10-11/h2,4-7,10,16H,3,8-9H2,1H3/b7-6+
InChI Key:	VRYKTHBAWRESFI-VOTSOKGWSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/5281087

External links:
Guide to Pharmacology:	oxantel
Citations:	http://aac.asm.org/content/58/1/378.full https://www.ncbi.nlm.nih.gov/pubmed/12913453